Watch Out!
Watch Out! Incredible breakthroughs in Science are breaking through this door.
Contact Us
Questions and/or comments about Corn Lab and its activities may be addressed to:
Lab News
Sharon Feng receives the SURF Rose Hills fellowship
Congratulations to our undergraduate researcher, Sharon Feng! She will receive the Summer Undergraduate Research Fellowships— Rose Hills ...
Congratulations to our undergraduate researcher, Sharon Feng! She will receive the Summer Undergraduate Research Fellowships— Rose Hills Experience to continue her research during summer.
How-to-guide to use Cas9 RNP for high efficiency genome editing
IGI Project Scientist Mark DeWitt and Scientific Director Jacob Corn have published a paper ” Genome editing via delivery of Cas9 ribonucleoprotein...
IGI Project Scientist Mark DeWitt and Scientific Director Jacob Corn have published a paper ” Genome editing via delivery of Cas9 ribonucleoprotein” with our collaborator Professor Dana Carroll in Methods recently. This is a how-to guide for how to use the Cas9 RNP for high efficiency genome editing. It walks the reader through experimental design, the editing workflow itself, and analysis of edited cells.
Diane Ferris went to the March For Science in Washington
Diane Ferris and her son, Charlie Ferris Weiler were interviewed by the AAAS for their attendance at the March For Science in Washington. She joined ...
Congrats to our newest MCB PhD candidate—Mandy Boontanrart!
Congratulations to Mandy Boontanrart! She just passed her Qualifying Exam and became our newest MCB PhD candidate. She was wearing our Corn lab mascot costume in the celebration party.
Amos Liang receives grant from BrightFocus Foundation to study Alzheimer’s disease
Our postdoctoral fellow Amos Jin Rui Liang will receive $100,000.00 grant from the BrightFocus Foundation for his study of Alzheimer’s disease...
Our postdoctoral fellow Amos Jin Rui Liang will receive $100,000.00 grant from the BrightFocus Foundation for his study of Alzheimer’s disease focusing on the “Identification of Novel ER-phagy Proteins that are Implicated in Neurodegeneration”
#1 spot in the Media Highlights: The 10 Essential Stories of 2016
The top UC Berkeley story last year features our postdoctoral fellow Mark Dewitt using the CRISPR-Cas9 gene-editing tool to cure the sickle cell disease. ...
The top UC Berkeley story last year features our postdoctoral fellow Mark Dewitt using the CRISPR-Cas9 gene-editing tool to cure the sickle cell disease. The #1 spot in the Media Highlights: The 10 Essential Stories of 2016. His work was also picked up by dozens of sources, including the Los Angeles Times, Mercury News, Nature, The Scientist, Cosmos Magazine, and GenomeWeb. Roxanne Makasdjian and Stephen McNally produced a video that accompanied the press release and many versions of the story.
Welcome, Jonathan Vu!
We're delighted to welcome Jonathan to join our lab as a Research Associate. He has been working as a volunteer before and will continue to work with Mark DeWitt in the sickle cell research project.
Thomas Barnes from Intellia Therapeutics gave a talk to Corn Lab
The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative...
The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative Sciences & eXtellia, and his teams shared their scientific expertise in CRISPR/Cas9 technology and clinical development experience to the members in Corn lab.
Benjamin Gowen will attend the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference
Corn Lab post-doc Benjamin Gowen is attending the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference in Whistler, British Columbia ...
Corn Lab post-doc Benjamin Gowen is attending the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference in Whistler, British Columbia from March 26-30, 2017. If you’re attending the meeting, you should come by poster #1030 to see his work on the discovery of an autoimmunity-associated IL2RA enhancer.
